Showing 4481-4500 of 8875 for: Cochrane Systematic Reviews Back
- Intravesical gemcitabine for non‐muscle invasive bladder cancer
Cochrane Systematic Reviews, 14-Jun-2021
It remains unclear whether people with non-muscle invasive bladder cancer (NMIBC) benefit from intravesical gemcitabine compared to other agents in the primary or recurrent setting following transurethral resection of a bladder tumor. This is an update of
- Intravesical treatments for painful bladder syndrome/ interstitial cystitis
Cochrane Systematic Reviews, 17-Oct-2007
Painful Bladder Syndrome/Interstitial Cystitis (PBS/IC) occurs predominantly in women. It is a poorly-understood condition with symptoms of bladder pain, urinary frequency, urgency and nocturia. Treatments for PBS/IC include dietary/lifestyle intervention
- Intravitreal low molecular weight heparin and 5‐Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery
Cochrane Systematic Reviews, 31-Jan-2013
Proliferative vitreoretinopathy (PVR) is a significant cause of failure in retinal reattachment surgery. Various pharmacological agents have shown potential benefit in reducing postoperative PVR risk.
- Intravitreal steroids for macular edema in diabetes
Cochrane Systematic Reviews, 17-Nov-2020
Diabetic macular edema (DME) is secondary to leakage from diseased retinal capillaries with thickening of central retina, and is an important cause of poor central visual acuity in people with diabetic retinopathy. Intravitreal steroids have been used to
- Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion
Cochrane Systematic Reviews, 9-Sep-2015
Central retinal vein occlusion (CRVO) is a common retinal vascular abnormality associated with conditions such as hypertension, diabetes, glaucoma, and a wide variety of hematologic disorders. Macular edema (ME) represents an important vision-threatening
- Invasive urodynamic studies for the management of lower urinary tract symptoms (LUTS) in men with voiding dysfunction
Cochrane Systematic Reviews, 21-Apr-2015
Invasive urodynamic tests are used to investigate men with lower urinary tract symptoms (LUTS) and voiding dysfunction to determine a definitive objective diagnosis. The aim is to help clinicians select the treatment that is most likely to be successful.
- Invasive versus non‐invasive ventilation for acute respiratory failure in neuromuscular disease and chest wall disorders
Cochrane Systematic Reviews, 4-Dec-2017
Acute respiratory failure is a common life-threatening complication of acute onset neuromuscular diseases, and may exacerbate chronic hypoventilation in patients with neuromuscular disease or chest wall disorders. Standard management includes oxygen suppl
- In-work tax credits for families and their impact on health status in adults
Cochrane Systematic Reviews, 1-Aug-2013
By improving two social determinants of health (poverty and unemployment) in low- and middle-income families on or at risk of welfare, in-work tax credit for families (IWTC) interventions could impact health status and outcomes in adults.
- Iodine fortification of foods and condiments, other than salt, for preventing iodine deficiency disorders
Cochrane Systematic Reviews, 11-Feb-2019
Iodine deficiency disorders (IDD) affect close to 1.9 billion people worldwide, and are a major public health concern in many countries. Among children, iodine deficiency is the main cause of potentially preventable deficits of central nervous system deve
- Iodine supplementation for preventing iodine deficiency disorders in children
Cochrane Systematic Reviews, 28-Nov-2018
Iodine deficiency is the main cause of potentially preventable mental retardation in childhood, as well as causing goitre and hypothyroidism in people of all ages. It is still prevalent in large parts of the world.
- Iodine supplementation for the prevention of mortality and adverse neurodevelopmental outcomes in preterm infants
Cochrane Systematic Reviews, 25-Feb-2019
Parenteral nutrition solutions, artificial formulas, and human breast milk contain insufficient iodine to meet recommended intakes for preterm infants. Iodine deficiency may exacerbate transient hypothyroxinaemia in preterm infants and this may be associa
- Iodine supplementation for women during the preconception, pregnancy and postpartum period
Cochrane Systematic Reviews, 5-Mar-2017
Iodine is an essential nutrient required for the biosynthesis of thyroid hormones, which are responsible for regulating growth, development and metabolism. Iodine requirements increase substantially during pregnancy and breastfeeding. If requirements are
- Iodine‐131‐meta‐iodobenzylguanidine therapy for patients with newly diagnosed high‐risk neuroblastoma
Cochrane Systematic Reviews, 21-Apr-2017
Patients with newly diagnosed high-risk (HR) neuroblastoma (NBL) still have a poor outcome, despite multi-modality intensive therapy. This poor outcome necessitates the search for new therapies, such as treatment with 131I-meta-iodobenzylguanidine (131I-M
- Iodised salt for preventing iodine deficiency disorders
Cochrane Systematic Reviews, 10-Nov-2008
Iodine deficiency is the main cause for potentially preventable mental retardation in childhood, as well as causing goitre and hypothyroidism in people of all ages. It is still prevalent in large parts of the world.
- Ionisers for chronic asthma
Cochrane Systematic Reviews, 12-Sep-2012
Previous reports have shown that ion content in the air may have an effect on respiratory function. Results from studies which test the efficacy of air ionisers to reduce asthma symptoms are often inconclusive and their use as a treatment for asthma remai
- Ipratropium bromide versus long‐acting beta‐2 agonists for stable chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 19-Jul-2006
Chronic obstructive pulmonary disease (COPD) is a condition associated with high morbidity, mortality and cost to the community. Patients often report symptomatic improvement with long acting beta-2 agonists (LABAs) and anticholinergic bronchodilator medi
- Ipratropium bromide versus short acting beta‐2 agonists for stable chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 19-Apr-2006
Chronic obstructive pulmonary disease (COPD) is a condition associated with high morbidity, mortality and cost to the community. Patients often report symptomatic improvement with short-acting beta-2 agonists (SABA) and anticholinergic bronchodilator medi
- Iridotomy to slow progression of visual field loss in angle‐closure glaucoma
Cochrane Systematic Reviews, 9-Jan-2023
Primary angle-closure glaucoma is a type of glaucoma associated with a physically obstructed anterior chamber angle. For example, contact between the iris and lens at the pupillary margin creates a pupillary block that increases resistance to aqueous outf
- Irinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for overall survival and progression‐free survival in patients with advanced and/or metastatic colorectal cancer
Cochrane Systematic Reviews, 12-Feb-2016
Chemotherapy is the treatment of choice in patients with advanced or metastatic colorectal cancer (CRC) where surgical resection of metastases is not an option. Both irinotecan (IRI) and fluoropyrimidines are often included in first- or second- line chemo
- Iron and folate supplementation in pregnancy
Cochrane Systematic Reviews, 20-Oct-2008
Anaemia in pregnancy is a major health problem in many developing countries where nutritional deficiency, malaria and other parasitic infections contribute to increased maternal and perinatal mortality and morbidity.
